Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03644693 · ClinicalTrials.gov registry record · NA
Nutritional Formulation for Angelman Syndrome
A NA study of Angelman Syndrome, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT03644693 is a NA study of Angelman Syndrome that has completed, run by University of Colorado, Denver. The registered enrollment target is 15 participants, below the 125-participant average among 11 other Angelman Syndrome trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03644693, a NA study of Angelman Syndrome, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Low carbohydrate diets such as the ketogenic (KD) and low glycemic index (LGIT) diets have been shown to be effective in treating drug resistant seizures in children with Angelman syndrome (AS). The investigators hypothesize that consuming a fat based nutritional formulation with an exogenous ketone throughout the day will produce urinary ketosis in children consuming both low and high carbohydrate diets, depending upon dietary background. The nutritional formulation will provide fuel substrates that push metabolism away from carbohydrates and towards fat utilization. This research is being done to assess the safety and tolerability of a nutritional formulation for use in dietary interventions in AS.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Nutritional Formulation Containing Exogenous Ketones
- DIETARY_SUPPLEMENT Placebo Formulation
Study Locations (1)
Colorado
- Children's Hopsital Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-11-01 |
| Est. Completion | 2020-01-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03644693
The ClinicalTrials.gov registry entry for NCT03644693 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 11 other Angelman Syndrome trials with a reported enrollment target (88% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Angelman Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Nutritional Formulation Containing Exogenous Ketones is the first listed.
NCT03644693 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03644693 about?
NCT03644693 is a clinical study titled "Nutritional Formulation for Angelman Syndrome". Low carbohydrate diets such as the ketogenic (KD) and low glycemic index (LGIT) diets have been shown to be effective in treating drug resistant seizures in children with Angelman syndrome (AS). The investigators hypothesize that consuming a fat based nutritional formulation with an exogenous ketone...
What is the current status of trial NCT03644693?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-11-01. Estimated completion is 2020-01-15.
What conditions does trial NCT03644693 study?
This clinical trial studies the following conditions: Angelman Syndrome.
What interventions are being tested in trial NCT03644693?
The interventions under investigation include: Nutritional Formulation Containing Exogenous Ketones (DIETARY_SUPPLEMENT), Placebo Formulation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03644693?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03644693 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Angelman Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
RECRUITING · NA
-
Dietary Supplements for the Treatment of Angelman Syndrome
COMPLETED · NA
-
Angelman Syndrome Natural History Study
RECRUITING
-
REVEAL: A Phase 3 Study of ION582 in Angelman Syndrome
RECRUITING · Phase 3
-
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
RECRUITING · Phase 1
-
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.